IBDEI0FH ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20765,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20765,1,1,0)
 ;;=1^204.00
 ;;^UTILITY(U,$J,358.3,20765,1,8,0)
 ;;=8^ALL w/o Remission
 ;;^UTILITY(U,$J,358.3,20765,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,20766,0)
 ;;=204.01^^132^1236^3
 ;;^UTILITY(U,$J,358.3,20766,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20766,1,1,0)
 ;;=1^204.01
 ;;^UTILITY(U,$J,358.3,20766,1,8,0)
 ;;=8^ALL,in Remission
 ;;^UTILITY(U,$J,358.3,20766,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,20767,0)
 ;;=204.10^^132^1236^5
 ;;^UTILITY(U,$J,358.3,20767,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20767,1,1,0)
 ;;=1^204.10
 ;;^UTILITY(U,$J,358.3,20767,1,8,0)
 ;;=8^CLL w/o Remission
 ;;^UTILITY(U,$J,358.3,20767,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,20768,0)
 ;;=204.11^^132^1236^7
 ;;^UTILITY(U,$J,358.3,20768,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20768,1,1,0)
 ;;=1^204.11
 ;;^UTILITY(U,$J,358.3,20768,1,8,0)
 ;;=8^CLL,in Remission
 ;;^UTILITY(U,$J,358.3,20768,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,20769,0)
 ;;=201.90^^132^1236^11
 ;;^UTILITY(U,$J,358.3,20769,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20769,1,1,0)
 ;;=1^201.90
 ;;^UTILITY(U,$J,358.3,20769,1,8,0)
 ;;=8^Hodgkin's Lymphoma,Unspec Type
 ;;^UTILITY(U,$J,358.3,20769,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,20770,0)
 ;;=202.00^^132^1236^19
 ;;^UTILITY(U,$J,358.3,20770,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20770,1,1,0)
 ;;=1^202.00
 ;;^UTILITY(U,$J,358.3,20770,1,8,0)
 ;;=8^Lymphoma,Low-Grade (Nodular)
 ;;^UTILITY(U,$J,358.3,20770,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,20771,0)
 ;;=200.20^^132^1236^16
 ;;^UTILITY(U,$J,358.3,20771,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20771,1,1,0)
 ;;=1^200.20
 ;;^UTILITY(U,$J,358.3,20771,1,8,0)
 ;;=8^Lymphoma,Burkitts
 ;;^UTILITY(U,$J,358.3,20771,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,20772,0)
 ;;=202.10^^132^1236^29
 ;;^UTILITY(U,$J,358.3,20772,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20772,1,1,0)
 ;;=1^202.10
 ;;^UTILITY(U,$J,358.3,20772,1,8,0)
 ;;=8^Mycosis Fungoides
 ;;^UTILITY(U,$J,358.3,20772,2)
 ;;=^80360
 ;;^UTILITY(U,$J,358.3,20773,0)
 ;;=273.3^^132^1236^21
 ;;^UTILITY(U,$J,358.3,20773,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20773,1,1,0)
 ;;=1^273.3
 ;;^UTILITY(U,$J,358.3,20773,1,8,0)
 ;;=8^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,20773,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,20774,0)
 ;;=203.00^^132^1236^28
 ;;^UTILITY(U,$J,358.3,20774,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20774,1,1,0)
 ;;=1^203.00
 ;;^UTILITY(U,$J,358.3,20774,1,8,0)
 ;;=8^Multiple Myeloma,W/O Remission
 ;;^UTILITY(U,$J,358.3,20774,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,20775,0)
 ;;=203.01^^132^1236^27
 ;;^UTILITY(U,$J,358.3,20775,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20775,1,1,0)
 ;;=1^203.01
 ;;^UTILITY(U,$J,358.3,20775,1,8,0)
 ;;=8^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,20775,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,20776,0)
 ;;=202.40^^132^1236^8
 ;;^UTILITY(U,$J,358.3,20776,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20776,1,1,0)
 ;;=1^202.40
 ;;^UTILITY(U,$J,358.3,20776,1,8,0)
 ;;=8^Hairy-Cell Leukemia
 ;;^UTILITY(U,$J,358.3,20776,2)
 ;;=^69587
 ;;^UTILITY(U,$J,358.3,20777,0)
 ;;=200.10^^132^1236^18
 ;;^UTILITY(U,$J,358.3,20777,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20777,1,1,0)
 ;;=1^200.10
 ;;^UTILITY(U,$J,358.3,20777,1,8,0)
 ;;=8^Lymphoma,Int/High (Diffuse)
 ;;^UTILITY(U,$J,358.3,20777,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,20778,0)
 ;;=273.1^^132^1236^25
 ;;^UTILITY(U,$J,358.3,20778,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20778,1,1,0)
 ;;=1^273.1
 ;;^UTILITY(U,$J,358.3,20778,1,8,0)
 ;;=8^Monoclon Paraproteinemia
 ;;^UTILITY(U,$J,358.3,20778,2)
 ;;=^78888
 ;;^UTILITY(U,$J,358.3,20779,0)
 ;;=238.79^^132^1236^20
 ;;^UTILITY(U,$J,358.3,20779,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20779,1,1,0)
 ;;=1^238.79
 ;;^UTILITY(U,$J,358.3,20779,1,8,0)
 ;;=8^Lymphoproliferat Dis
 ;;^UTILITY(U,$J,358.3,20779,2)
 ;;=^334033
 ;;^UTILITY(U,$J,358.3,20780,0)
 ;;=202.90^^132^1236^17
 ;;^UTILITY(U,$J,358.3,20780,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20780,1,1,0)
 ;;=1^202.90
 ;;^UTILITY(U,$J,358.3,20780,1,8,0)
 ;;=8^Lymphoma,Diffuse,Unspec Site
 ;;^UTILITY(U,$J,358.3,20780,2)
 ;;=^267504
 ;;^UTILITY(U,$J,358.3,20781,0)
 ;;=200.30^^132^1236^23
 ;;^UTILITY(U,$J,358.3,20781,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20781,1,1,0)
 ;;=1^200.30
 ;;^UTILITY(U,$J,358.3,20781,1,8,0)
 ;;=8^Marginal Zone Lymphoma
 ;;^UTILITY(U,$J,358.3,20781,2)
 ;;=^335296
 ;;^UTILITY(U,$J,358.3,20782,0)
 ;;=200.40^^132^1236^22
 ;;^UTILITY(U,$J,358.3,20782,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20782,1,1,0)
 ;;=1^200.40
 ;;^UTILITY(U,$J,358.3,20782,1,8,0)
 ;;=8^Mantle Cell Lymphoma
 ;;^UTILITY(U,$J,358.3,20782,2)
 ;;=^335297
 ;;^UTILITY(U,$J,358.3,20783,0)
 ;;=200.50^^132^1236^32
 ;;^UTILITY(U,$J,358.3,20783,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20783,1,1,0)
 ;;=1^200.50
 ;;^UTILITY(U,$J,358.3,20783,1,8,0)
 ;;=8^Prim CNS Lymphoma
 ;;^UTILITY(U,$J,358.3,20783,2)
 ;;=^335298
 ;;^UTILITY(U,$J,358.3,20784,0)
 ;;=200.60^^132^1236^4
 ;;^UTILITY(U,$J,358.3,20784,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20784,1,1,0)
 ;;=1^200.60
 ;;^UTILITY(U,$J,358.3,20784,1,8,0)
 ;;=8^Anaplastic Large Cell Lymphoma
 ;;^UTILITY(U,$J,358.3,20784,2)
 ;;=^335299
 ;;^UTILITY(U,$J,358.3,20785,0)
 ;;=200.70^^132^1236^13
 ;;^UTILITY(U,$J,358.3,20785,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20785,1,1,0)
 ;;=1^200.70
 ;;^UTILITY(U,$J,358.3,20785,1,8,0)
 ;;=8^Large Cell Lymphoma
 ;;^UTILITY(U,$J,358.3,20785,2)
 ;;=^335300
 ;;^UTILITY(U,$J,358.3,20786,0)
 ;;=200.80^^132^1236^31
 ;;^UTILITY(U,$J,358.3,20786,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20786,1,1,0)
 ;;=1^200.80
 ;;^UTILITY(U,$J,358.3,20786,1,8,0)
 ;;=8^Oth Named Variants
 ;;^UTILITY(U,$J,358.3,20786,2)
 ;;=^176827
 ;;^UTILITY(U,$J,358.3,20787,0)
 ;;=201.00^^132^1236^9
 ;;^UTILITY(U,$J,358.3,20787,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20787,1,1,0)
 ;;=1^201.00
 ;;^UTILITY(U,$J,358.3,20787,1,8,0)
 ;;=8^Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,20787,2)
 ;;=^265557
 ;;^UTILITY(U,$J,358.3,20788,0)
 ;;=201.10^^132^1236^10
 ;;^UTILITY(U,$J,358.3,20788,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20788,1,1,0)
 ;;=1^201.10
 ;;^UTILITY(U,$J,358.3,20788,1,8,0)
 ;;=8^Hodgkin's Granuloma
 ;;^UTILITY(U,$J,358.3,20788,2)
 ;;=^58273
 ;;^UTILITY(U,$J,358.3,20789,0)
 ;;=201.20^^132^1236^12
 ;;^UTILITY(U,$J,358.3,20789,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20789,1,1,0)
 ;;=1^201.20
 ;;^UTILITY(U,$J,358.3,20789,1,8,0)
 ;;=8^Hodgkin's Sarcoma
 ;;^UTILITY(U,$J,358.3,20789,2)
 ;;=^265560
 ;;^UTILITY(U,$J,358.3,20790,0)
 ;;=201.40^^132^1236^15
 ;;^UTILITY(U,$J,358.3,20790,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20790,1,1,0)
 ;;=1^201.40
 ;;^UTILITY(U,$J,358.3,20790,1,8,0)
 ;;=8^Lymphocytic-Histiocytic
 ;;^UTILITY(U,$J,358.3,20790,2)
 ;;=^265549
 ;;^UTILITY(U,$J,358.3,20791,0)
 ;;=201.50^^132^1236^30
 ;;^UTILITY(U,$J,358.3,20791,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20791,1,1,0)
 ;;=1^201.50
 ;;^UTILITY(U,$J,358.3,20791,1,8,0)
 ;;=8^Nodular Sclerosis
 ;;^UTILITY(U,$J,358.3,20791,2)
 ;;=^265555
 ;;^UTILITY(U,$J,358.3,20792,0)
 ;;=201.60^^132^1236^24
 ;;^UTILITY(U,$J,358.3,20792,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20792,1,1,0)
 ;;=1^201.60
 ;;^UTILITY(U,$J,358.3,20792,1,8,0)
 ;;=8^Mixed Cellularity
 ;;^UTILITY(U,$J,358.3,20792,2)
 ;;=^265551
 ;;^UTILITY(U,$J,358.3,20793,0)
 ;;=201.70^^132^1236^14
 ;;^UTILITY(U,$J,358.3,20793,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20793,1,1,0)
 ;;=1^201.70
 ;;^UTILITY(U,$J,358.3,20793,1,8,0)
 ;;=8^Lymphocytic Depletion
 ;;^UTILITY(U,$J,358.3,20793,2)
 ;;=^265553
 ;;^UTILITY(U,$J,358.3,20794,0)
 ;;=203.02^^132^1236^26
 ;;^UTILITY(U,$J,358.3,20794,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20794,1,1,0)
 ;;=1^203.02
 ;;^UTILITY(U,$J,358.3,20794,1,8,0)
 ;;=8^Multiple Myeloma in Relapse
 ;;^UTILITY(U,$J,358.3,20794,2)
 ;;=^336462
 ;;^UTILITY(U,$J,358.3,20795,0)
 ;;=204.02^^132^1236^2
 ;;^UTILITY(U,$J,358.3,20795,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20795,1,1,0)
 ;;=1^204.02
 ;;^UTILITY(U,$J,358.3,20795,1,8,0)
 ;;=8^ALL,in Relapse
 ;;^UTILITY(U,$J,358.3,20795,2)
 ;;=^336465
 ;;^UTILITY(U,$J,358.3,20796,0)
 ;;=204.12^^132^1236^6
 ;;^UTILITY(U,$J,358.3,20796,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20796,1,1,0)
 ;;=1^204.12
 ;;^UTILITY(U,$J,358.3,20796,1,8,0)
 ;;=8^CLL,in Relapse
 ;;^UTILITY(U,$J,358.3,20796,2)
 ;;=^336466
 ;;^UTILITY(U,$J,358.3,20797,0)
 ;;=156.2^^132^1237^1
 ;;^UTILITY(U,$J,358.3,20797,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20797,1,1,0)
 ;;=1^156.2
 ;;^UTILITY(U,$J,358.3,20797,1,8,0)
 ;;=8^Malig Neo Ampulla of Vater
 ;;^UTILITY(U,$J,358.3,20797,2)
 ;;=^267100
 ;;^UTILITY(U,$J,358.3,20798,0)
 ;;=154.3^^132^1237^2
 ;;^UTILITY(U,$J,358.3,20798,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20798,1,1,0)
 ;;=1^154.3
 ;;^UTILITY(U,$J,358.3,20798,1,8,0)
 ;;=8^Malig Neo Anus
 ;;^UTILITY(U,$J,358.3,20798,2)
 ;;=^267092
 ;;^UTILITY(U,$J,358.3,20799,0)
 ;;=156.1^^132^1237^3
 ;;^UTILITY(U,$J,358.3,20799,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20799,1,1,0)
 ;;=1^156.1
 ;;^UTILITY(U,$J,358.3,20799,1,8,0)
 ;;=8^Malig Neo Bile Ducts
 ;;^UTILITY(U,$J,358.3,20799,2)
 ;;=^267099
 ;;^UTILITY(U,$J,358.3,20800,0)
 ;;=153.9^^132^1237^5
 ;;^UTILITY(U,$J,358.3,20800,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20800,1,1,0)
 ;;=1^153.9
 ;;^UTILITY(U,$J,358.3,20800,1,8,0)
 ;;=8^Malig Neo Colon
 ;;^UTILITY(U,$J,358.3,20800,2)
 ;;=^267078
 ;;^UTILITY(U,$J,358.3,20801,0)
 ;;=150.9^^132^1237^6
 ;;^UTILITY(U,$J,358.3,20801,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20801,1,1,0)
 ;;=1^150.9
 ;;^UTILITY(U,$J,358.3,20801,1,8,0)
 ;;=8^Malig Neo Esophagus
 ;;^UTILITY(U,$J,358.3,20801,2)
 ;;=^267055
 ;;^UTILITY(U,$J,358.3,20802,0)
 ;;=156.0^^132^1237^14
 ;;^UTILITY(U,$J,358.3,20802,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20802,1,1,0)
 ;;=1^156.0
